# Real-World Evaluation of GLP-1 Receptor Agonist Therapy Persistence, Adherence and Therapeutic Inertia Among Obese Adults with Type 2 Diabetes

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/real-world-evaluation-of-glp-1-receptor-agonist-therapy-persistence-adherence/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Ana Palanca,Francisco Javier Ampudia‐Blasco,José Miguel Calderón,Inmaculada Saurí,Sergio Martínez‐Hervás,José Luís Trillo,Josep Redón,José T. Real |
| Citations | 47 |
| DOI | 10.1007/s13300-023-01382-9 |
| Fields | Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://link.springer.com/content/pdf/10.1007/s13300-023-01382-9.pdf |
| OpenAlex ID | https://openalex.org/W4322495046 |
| PMID | 36847952 |
| Type | article |
| Year | 2023 |

## Paper authors

- [Sergio Martínez‐Hervás](https://scholariq.org/researchers/sergio-martinez-hervas/)

## Paper journal

- [Diabetes Therapy](https://scholariq.org/journals/diabetes-therapy/)

## Paper primary topic

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)

## Paper topics

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Medication Adherence and Compliance](https://scholariq.org/topics/medication-adherence-and-compliance/)
- [Diabetes, Cardiovascular Risks, and Lipoproteins](https://scholariq.org/topics/diabetes-cardiovascular-risks-and-lipoproteins/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.